ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) is a rare and heterogeneous subtype of SM and few studies on this specific entity have been reported. Sixty two patients with Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-A...

Full description

Bibliographic Details
Main Authors: Gandhi Damaj, Magalie Joris, Olivia Chandesris, Katia Hanssens, Erinn Soucie, Danielle Canioni, Brigitte Kolb, Isabelle Durieu, Emanuel Gyan, Cristina Livideanu, Stephane Chèze, Momar Diouf, Reda Garidi, Sophie Georgin-Lavialle, Vahid Asnafi, Ludovic Lhermitte, Christian Lavigne, David Launay, Michel Arock, Olivier Lortholary, Patrice Dubreuil, Olivier Hermine
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3897447?pdf=render

Internet

http://europepmc.org/articles/PMC3897447?pdf=render

Similar Items